跳至主要内容
临床试验/NCT02530944
NCT02530944已完成不适用

Web-based Genetic Research on Lupus

23andMe, Inc.1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
23andMe, Inc.
入组人数
5,000
试验地点
1
主要终点
Online survey

研究概览

简要总结

The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.

详细描述

Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with lupus by a qualified physician.
  • consents to have 23andMe (via a partner) contact the physician to obtain medical record information
  • willing to submit a saliva sample for DNA testing and complete online surveys related to condition
  • at least 6 years old (minors under 18 require parental consent to enroll)
  • access to the internet
  • resides in the United States

排除标准

  • 未提供

结局指标

主要结局

Online survey

时间窗: 12 months

Questions about lupus experience, symptoms and response to treatment

Salivary DNA sample for genetic analysis

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
23andMe, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验